Your browser doesn't support javascript.
loading
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease.
Hung, Lin W; Villemagne, Victor L; Cheng, Lesley; Sherratt, Nicki A; Ayton, Scott; White, Anthony R; Crouch, Peter J; Lim, SinChun; Leong, Su Ling; Wilkins, Simon; George, Jessica; Roberts, Blaine R; Pham, Chi L L; Liu, Xiang; Chiu, Francis C K; Shackleford, David M; Powell, Andrew K; Masters, Colin L; Bush, Ashley I; O'Keefe, Graeme; Culvenor, Janetta G; Cappai, Roberto; Cherny, Robert A; Donnelly, Paul S; Hill, Andrew F; Finkelstein, David I; Barnham, Kevin J.
Affiliation
  • Hung LW; The Mental Health Research Institute, the University of Melbourne, Victoria 3010 Australia.
J Exp Med ; 209(4): 837-54, 2012 Apr 09.
Article in En | MEDLINE | ID: mdl-22473957
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Organometallic Compounds / Parkinson Disease / Thiosemicarbazones / Cognition / Neuroprotective Agents / Radiopharmaceuticals / Motor Activity Limits: Animals / Humans / Male Language: En Year: 2012 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Organometallic Compounds / Parkinson Disease / Thiosemicarbazones / Cognition / Neuroprotective Agents / Radiopharmaceuticals / Motor Activity Limits: Animals / Humans / Male Language: En Year: 2012 Type: Article